NASDAQ NMS - GLOBAL MARKET · BRTX
-0.45% · -$0.0010 · Vol 76.2K
Market closed · last close 4:00 PM ET · price as of 19:50:18 ET
BioRestorative Therapies Inc

BioRestorative Therapies Inc

Biotechnology
$0.2196
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
BRTX
BioRestorative Therapies Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BRTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BRTX catalysts
About BioRestorative Therapies Inc
SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
Listed since
1997
Employees
14
Country
US

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.2230
Day high
$0.2230
Day low
$0.2136
Previous close
$0.2206
52W high
$1.84
-88.07% from high
52W low
$0.1698
3% of range
Market cap
$5.5M
EPS
$-1.3900
Beta
1.10
Shares out
25.5M
Volume
76.2K
0.24× rel vol
Avg volume
322.2K
VWAP
$0.2180
Price history computed in-house
1W
-0.18%
1M
-24.28%
3M
-12.09%
1Y
-85.65%
YTD
-81.31%
SMA 50 $0.3046 · below
SMA 200 $0.5748 · below
52W position 3%

BRTX overview

Veridion Score
65
Registered · 2026-08-21
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around BRTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading BRTX Form 4 filings
Public disclosures

Congress activity in BRTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for BRTX in the cached public ledger.

Federal contracts

BRTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BRTX in this window.
Lobbying spend

BRTX lobbying filings, year to date.

Registered lobbying filings matched to BioRestorative Therapies Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BRTX in this window.
Loading news for BRTX
Analyst ratings
Sovereign unlock shows live analyst consensus for BRTX.
Options
Sovereign unlock shows live options positioning for BRTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.